Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
IET Nanobiotechnol ; 9(4): 178-83, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26224346

ABSTRACT

The catalytic reduction of methylene blue was studied using biosynthesised gold-silver (Au-Ag) alloy nanoparticles (NPs). The fungal biomass of Trichoderma harzianum was used as a reducing and stabilising agent in the synthesis of Au-Ag alloy NPs. The synthesised NPs were well characterised by UV-vis spectroscopy, dynamic light scattering, X-ray diffraction, transmission electron microscopy, energy dispersive X-ray spectroscopy and Fourier transform infrared spectroscopy. The plausible synthesis mechanism involved in the formation of Au-Ag alloy NPs was also discussed with diagrammatic representation. A series of experiments was performed to investigate the catalytic activity of the as-prepared Au-Ag alloy NPs and found that the alloy NPs show excellent catalytic activity.


Subject(s)
Biotechnology/methods , Gold Alloys/chemistry , Metal Nanoparticles/chemistry , Nanotechnology/methods , Silver/chemistry , Trichoderma/metabolism , Gold Alloys/metabolism , Silver/metabolism
2.
Indian J Cancer ; 52(3): 430-7, 2015.
Article in English | MEDLINE | ID: mdl-26905160

ABSTRACT

BACKGROUND: We have reported here the 5-year incidence (2004-2008) of gallbladder cancer (GBC) in North Central India along with its descriptive epidemiology. This provides potential clues for better prevention. The present study has also evaluated the association of ABO blood groups with GBC. PATIENTS AND METHODS: The study comprised 742 GBC cases referred to the regional cancer hospital, Gwalior, during 2004-2008. The demographic statistics of Gwalior district was considered to calculate the relative risk and incidence rates. ABO blood group distribution amongst 90,000 healthy subjects registered in the local blood bank during 2002-2007 was taken as controls to study the association of blood groups with GBC. RESULTS: The age-standardized total incidence rate of GBC was calculated to be 7.16/1,00,000. The relative risk of females getting GBC was 2.693 at 95% confidence interval of 2.304-3.151 (P < 0.0001). The females formed 69.5% of total cancer cases, with age-standardized incidence rate of 10/1,00,000. The mean age of male and female GBC cases was found to be 55.4 years (SD = 13, SE = 0.77) and 51.5 years (SD = 12.3, SE = 0.50), respectively. The blood groups A (P = 0.0022) and AB (P < 0.0001) had a positive association with GBC with significant level of differences in comparison to controls. CONCLUSION: Our study provided an estimate of a 5-year incidence of GBC in North Central India for the first time. With regard to the association of risk factors like obesity, age, and urban living with GBC, the findings of the present study are contradictory to the general opinion. Blood groups A and AB were found to be associated with GBC, which would be provisional for further investigations.


Subject(s)
Gallbladder Neoplasms/epidemiology , ABO Blood-Group System , Female , Humans , Incidence , India/epidemiology , Male , Middle Aged , Risk Factors , Time Factors
3.
Artif Cells Nanomed Biotechnol ; 43(5): 311-7, 2015.
Article in English | MEDLINE | ID: mdl-24588231

ABSTRACT

Gold nanoparticles have tremendous application in the area of nanotechnology that raises new possibility in the treatment of brain tumor. These nanoparticles can be used for selectively gaining access to tumor due to their small size and modifiability. Gold nanoparticles are functionalized with various molecules such as anticancer drug, transferrin and monoclonal antibody to produce nanocarriers. These nanocarriers have ability to deliver the drug at targeted site. Transferrin crosses the blood-brain barrier because of the receptor-mediated endocytosis. The monoclonal antibody facilitates the release of anticancer drug at targeted sites. This approach of delivery saves the normal cells surrounding the tumor.


Subject(s)
Antineoplastic Agents/therapeutic use , Brain Neoplasms/drug therapy , Drug Delivery Systems/methods , Gold/chemistry , Metal Nanoparticles/chemistry , Antineoplastic Agents/chemistry , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Humans
4.
J Photochem Photobiol B ; 141: 288-95, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25463680

ABSTRACT

We demonstrate a novel, unprecedented and eco-friendly mode for the biosynthesis of zinc oxide (ZnO) nanoflowers at ambient room temperature using Bacillus licheniformis MTCC 9555 and assessed their photocatalytic activity. The photocatalytic degradation of methylene blue (MB) dye was analyzed under UV-irradiation. An enhanced photocatalytic activity of ZnO nanoflowers was obtained compared to the earlier reports on ZnO nanostructures and other photocatalytic materials. The mechanism behind the enhanced photocatalytic activity was illustrated with diagrammatic representation. It is assumed that due to larger content of oxygen vacancy ZnO nanoflowers shows enhanced photocatalytic activity. Photostability of ZnO nanoflowers was analyzed for consecutive 3 cycles. The size and morphology of ZnO nanoflowers have been characterized by SEM, TEM and found to be in the size range of 250 nm to 1 µm with flower like morphology. It was found that ZnO nanoflowers was formed by agglomeration of ZnO nanorods. Further the EDX established the presence of the elemental signal of the Zn and O. XRD spectrum of ZnO nanoflowers confirmed 2θ values analogous to the ZnO nanocrystal. FTIR analysis was carried to determine the probable biomolecules responsible for stabilization of ZnO nanoflowers. The plausible mechanism behind the synthesis of ZnO nanoflowers by Bacillus licheniformis MTCC 9555 was also discussed with diagram representation.


Subject(s)
Nanostructures/chemistry , Zinc Oxide/chemistry , Bacillus/chemistry , Bacillus/metabolism , Biomass , Catalysis , Methylene Blue/chemistry , Particle Size , Photolysis/radiation effects , Spectrometry, X-Ray Emission , Spectroscopy, Fourier Transform Infrared , Ultraviolet Rays , X-Ray Diffraction
5.
Indian J Cancer ; 49(1): 125-36, 2012.
Article in English | MEDLINE | ID: mdl-22842180

ABSTRACT

AIM OF STUDY: To investigate the trend of expression of liver function test enzymes and other biochemical changes during gallbladder carcinogenesis. MATERIALS AND METHODS: Eight hundred and seventy-eight gallbladder disease patients were selected to study the liver function test enzymes and routine blood biochemical changes in the last five years (2004-08). Statistical analysis was performed using Graph Pad prism 5.02 software. RESULTS: The liver function test enzymes showed significant correlations among themselves, and with glucose in gallbladder cancer and gallstone disease patients (N = 878). Out of 878 gallbladder cases, 46 (5.24%) showed significantly higher glucose level of 216.66 mg/dL (P < 0.0001). All the three pathological conditions of gallbladder, gallbladder cancer with stones (GBCS), gallbladder cancer without stones (GBC) and calculus cholecystitis (CC), showed highly significant positive correlation (Pearson) between Serum Glutamic Oxaloactetic Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT) [P < 0.0001, (GBCS); P < 0.0001, (GBC), and P < 0.0001, (CC)]. SGOT and SGPT also showed positive correlation with higher glucose level independently, in both GBCS and CC (P < 0.0001 and P < 0.0001), respectively. CONCLUSION: Simultaneous elevation of glucose and liver function test enzymes in GBC makes the diagnosis complex. Any patient of gallbladder diseases with higher level of glucose may have the possibility of developing gallbladder cancer.


Subject(s)
Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Gallbladder Neoplasms , Liver/enzymology , Adult , Aged , Aged, 80 and over , Alkaline Phosphatase/blood , Blood Glucose , Female , Gallbladder/enzymology , Gallbladder/pathology , Gallbladder Neoplasms/blood , Gallbladder Neoplasms/diagnosis , Gallbladder Neoplasms/pathology , Humans , India , Liver Function Tests , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...